The FDA has now green-lighted a new anti-viral drug from pharmaceutical giant Merck to help fight the coronavirus.
The Details: The pill, molnupiravir, was approved for adults at high risk of hospitalization and death from Covid-19 but the agency claimed that it shouldn’t be treated as a ‘preferred’ treatment.
The treatment is expected to be available for the public in only a few weeks.
The pill works by reportedly entering errors into the coronavirus’s genes to stop it from reproducing.
The news comes in the wake of the FDA ok’ing a similar treatment from Pfizer.
President Biden recently announced his intention to make 500 million at-home tests available to Americans concerned by infection.